The Veterinary Oncology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for veterinary oncology expanded quickly in recent years, growing from $0.4 billion in 2024 to $0.45 billion in 2025. This represents a compound annual growth rate (CAGR) of 12.3%.
The projected market size of the global Veterinary Oncology market in 2029 is expected to be $0.69 billion, growing at a compound annual growth rate (CAGR) of 11.0%.
Download Your Free Sample of the 2025 Veterinary Oncology Market Report and Uncover Key Trends Now!The key drivers in the veterinary oncology market are:
• Personalized medicine for animals driving demand
• Rising prevalence of cancer in animals
• Growth of the geriatric pet population
• Increased access to specialized veterinary care and regulatory support
The veterinary oncology market covered in this report is segmented –
1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies
2) By Animal Type: Equine, Canine, Feline, Other Animal Types
3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types
The key trends in the veterinary oncology market are:
• Advanced diagnostic technologies are emerging as a significant trend.
• There is a move towards personalized treatment approaches.
• Advancements in immunotherapy are shaping the future of this market.
• Telemedicine in oncology consultations is a growing trend.
Major companies in the veterinary oncology market are:
• PetCure Oncology Inc.
• Zoetis Inc.
• Karyopharm Therapeutics Inc.
• Varian Medical Systems Inc.
• Accuray Incorporated
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Inc.
• One Health Company Inc.
• Regeneus Limited
• VetDC Inc.
• Pharmaust Limited
• AdvaVet Inc.
• Nippon Zenyaku Kogyo Company Limited
• Rhizen Pharmaceutical SA
• AB Science SAS
• Pfizer Inc.
• Takis Biotech GmbH
• Qbiotics LLC
• Jaguar Animal Health Solutions Inc.
• Orion Corporation A/B
• Invectys S.A.
• Virbac SA
• SeQuent Scientific Limited
• Ceva Santé Animale S.A.
• Vetoquinol S.A.
• IDVet Inc.
• Bayer Aktiengesellschaft
• Morphogenesis Inc.
• ZENOAQ GmbH
• Oncovet Clinical Research Inc.
The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain